Assessing Validity of Essentials in Minimally Invasive Gynecologic Surgery: Correlation with Global Operative Assessment of Laparoscopic Skills

Assessing Validity of Essentials in Minimally Invasive Gynecologic Surgery: Correlation with Global Operative Assessment of Laparoscopic Skills

This article analyzes the validity evidence for the Essentials in Minimally Invasive Gynecologic Surgery exam by correlating its performance scores with the Global Operative Assessment of Laparoscopic Skills, supporting its adoption as a summative evaluation for OB/GYN training.
Development and Validation of a Noninvasive Score for At-Risk Metabolic Dysfunction-Associated Steatohepatitis in Individuals with Obesity Undergoing Bariatric Surgery

Development and Validation of a Noninvasive Score for At-Risk Metabolic Dysfunction-Associated Steatohepatitis in Individuals with Obesity Undergoing Bariatric Surgery

Researchers developed and validated the FMO score, a noninvasive, cost-effective tool to identify at-risk metabolic dysfunction-associated steatohepatitis (MASH) in obese patients, showing strong predictive performance across multiple international cohorts.
Glucagon-like Peptide-1 Receptor Agonists Versus Dipeptidyl Peptidase-4 Inhibitors Following Liver Resection for Hepatocellular Carcinoma in Type 2 Diabetes: Insights from a Target Trial Emulation Study

Glucagon-like Peptide-1 Receptor Agonists Versus Dipeptidyl Peptidase-4 Inhibitors Following Liver Resection for Hepatocellular Carcinoma in Type 2 Diabetes: Insights from a Target Trial Emulation Study

Postoperative GLP-1RA initiation after liver resection for hepatocellular carcinoma in type 2 diabetes patients is associated with improved recurrence-free and overall survival compared to DPP-4 inhibitors, indicating potential incremental benefits of GLP-1RAs in this setting.